O'Melveny Reps Chinese Co. In $118M Complete Genomics Deal
Gene sequencing company Complete Genomics Inc. has agreed to let a U.S. subsidiary of Chinese rival BGI-Shenzhen snap it up in a merger deal worth about $117.6 million, the companies announced...To view the full article, register now.
Already a subscriber? Click here to view full article